GlucoTrack (GCTK) elects Victoria Carr-Brendel to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to GlucoTrack (GCTK) elects Victoria Carr-Brendel to Board

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025 8:30 AM EDT

Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology

RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Victoria E. Carr-Brendel, PhD, was elected to the Companys Board of Directors, effective May 22, 2025.

We are delighted to welcome Dr. Carr-Brendel to Glucotracks Board of Directors, said Paul V. Goode, PhD, President and Chief... More